ClinicalTrials.Veeva

Menu

Modified Pectoral Nerves Block Versus Serratus Plane Block in Major Breast Cancer Surgery

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Completed
Phase 2

Conditions

Postoperative Pain

Treatments

Drug: Bupivacaine 0.25% with epinephrine

Study type

Interventional

Funder types

Other

Identifiers

NCT02946294
MD2010014055.3
IRB00004025 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to compare the analgesic profile of modified pectoral nerves block and serratus plane block in patients undergoing mastectomy.

Full description

This study includes three groups. The first group will receive ultrasound-guided modified pectoral nerves block prior to induction of general anesthesia. The second one will receive ultrasound-guided serratus plane block prior to induction of general anesthesia. The third one will not receive any block preoperatively.

Enrollment

90 patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists( ASA) I or II and scheduled for major breast cancer surgery( modified radical mastectomy or conservative mastectomy with axillary evacuation).

Exclusion criteria

  • Local infection at the site of the block, coagulations abnormalities, allergy to local anesthetics or morphine, body mass index> 35, patient refusal, severe respiratory or cardiac disorders, pre-existing neurological deficits, hepatic or renal insufficiency, chronic pain syndrome, chronic analgesic use and psychiatric disorders.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 2 patient groups

modified pectoral nerves block
Active Comparator group
Description:
Modified pectoral nerves block with general anesthesia. Using the ultrasound, 10 ml of bupivacaine 0.25% with epinephrine 5 ug/ml will be injected in the plane between the pectoralis major and minor muscles. And another 20 ml of bupivacaine 0.25% with epinephrine 5 ug/ml will be injected in the plane between the pectoralis minor and the serratus anterior muscles.
Treatment:
Drug: Bupivacaine 0.25% with epinephrine
Drug: Bupivacaine 0.25% with epinephrine
serratus plane block
Active Comparator group
Description:
Serratus plane block with general anesthesia. Using the ultrasound, 0.4 ml of bupivacaine 0.25% with epinephrine 5 ug/ml will be injected in the plane between the serratus anterior muscle and the underlying ribs.
Treatment:
Drug: Bupivacaine 0.25% with epinephrine
Drug: Bupivacaine 0.25% with epinephrine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems